Incidence et facteurs de risque de la séroconversion au virus de l’hépatite C dans une cohorte d’usagers de drogue intraveineux du nord-est de la France

Dubois, 1997, Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group, Hepatology, 25, 1490, 10.1002/hep.510250630

Pillonel, 2001, Surveillance des marqueurs d’une infection par le VIH, l’HTLV et les virus des hépatites B et C chez les donneurs de sang en France, BEH, 46, 207

Conry-Cantilena, 1996, Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection, N Engl J Med, 334, 1691, 10.1056/NEJM199606273342602

Emmanuelli, 2003, Épidémiologie du VHC chez les usagers de drogues, France. 1993-2002, BEH, 16

Hagan, 1999, Syringe exchange and risk of infection with hepatitis B and C viruses, Am J Epidemiol, 149, 203, 10.1093/oxfordjournals.aje.a009792

Thorpe, 2002, Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment, Am J Epidemiol, 155, 645, 10.1093/aje/155.7.645

Miller, 2002, Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users, Hepatology, 36, 737, 10.1053/jhep.2002.35065

Hagan, 2001, Sharing of drug preparation equipment as a risk factor for hepatitis C, Am J Public Health, 91, 42, 10.2105/AJPH.91.1.42